Use of Atropine, Ondansetron, and Ketorolac for Treatment of Amniotic Fluid Embolism

Lauri Compton,Shawna Robertson
DOI: https://doi.org/10.1016/j.jogn.2024.05.142
2024-06-21
Abstract:The etiology of an amniotic fluid embolism (AFE) is not well understood. It is hypothesized to occur when the patient suffers a systemic immune response to amniotic fluid or fetal material that enters the blood stream during or shortly after labor. Most recently, the use of atropine, ondansetron, and ketorolac (AOK) are being widely discussed as a treatment option, although documented case studies with AOK treatment are limited.
nursing,obstetrics & gynecology
What problem does this paper attempt to address?